Search

everythinglearnresearchcommunity

for

Search:↓

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

IGFBP5 may be a potential target for Parkinson's treatment by reducing neuron death.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Some gonadal hormone drugs can block filovirus entry into cells.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

BTA safely and effectively treats hair loss, and works better with FNS.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

A specific gene mutation causes long hair in Angora rabbits.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

N,N-Dimethylglycine Sodium Salt helps reduce skin inflammation and improves skin cell growth and healing.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

A stable, active version of a growth factor was made in bacteria, showing promise for medical use.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Genosomes are promising for safe and effective gene delivery in therapy.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

The role of γδT-cells in causing alopecia areata remains unclear.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

GCN reduces lung inflammation and damage from air pollution in mice.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.